Vertex Pharmaceuticals (VRTX)

Net Income Growth

6.48%

Quarterly · Period ending:

VRTX logo

VRTX Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported6.48%
VRTX Quarterly Net Income YoY % (-20.00% → 6.48%)
High-resolution chart · PNG

VRTX net income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Net Income Growth — Quarterly
Period endingNet Income Growth
-195.9883%
45.108%
-762%
-73.8322%
216.787%
8.1875%
113.4921%
-521.7391%
-10.2041%
-109.5238%
-85.2941%
61.0169%
-600%
-44.8276%
-74.359%
6.3492%
93.722%
22.6667%
-387.5%
8.6957%
-147.7778%
-59.5745%
83.6735%
-76.9231%
-63.6364%
-46.875%
-156.3218%
-44.4444%
-587.5%
3.0303%
422.2222%
-22.7273%
57.8947%
-106.25%
-107.6923%
-83.3333%
-35.7143%
-33.3333%
-18.1818%
-9.0909%
-27.2727%
-20%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.